Health Care Industry News
Acura submits NDA for Acurox tabs
Pharmabiz.com (India) | 59 minutes ago
Acura Pharmaceuticals, Inc and King Pharmaceuticals, Inc announced that Acura has submitted a New Drug Application (NDA) for Acurox (oxycodone HCl/niacin) tablets to the US Food and Drug Administration (FDA) including a request for priority review. The FDA is expected to determine whether to accept the NDA for filing and consider the priority review request within 60 days. If approved, Acura and King believe Acurox will be the first FDA approved immediate release opioid analgesic designed to ...... (more)
Latest Health Care Industry NewsMore >
Daiichi to write-down loss of $3.98 bn in Q3 for Ranbaxy acquisition
Pharmabiz.com (India) | 59 minutes ago
Food Markets - Forbes.com
Forbes | 2 hours 52 minutes ago
Endo buy widens its drug offerings | delawareonline | The News Journal
News Journal (Del.), The | 2 hours 56 minutes ago
After years of research, tons of money, Memphis firm seeks FDA approval to sell Acapodene : Business News : Memphis Commercial Appeal
Commercial Appeal (Memphis, Tenn.), The | 2 hours 59 minutes ago
Readers ChoiceMore >
24 new medicines obtained FDA clearance in 2008
FDLI SmartBrief | Jan 02, 2009
Drug firms to stop giving promotional items to doctors
FDLI SmartBrief | Dec 31, 2008
Bone drugs may raise risk of esophageal cancer, FDA official says
FDLI SmartBrief | Jan 02, 2009
FDA orders further study on Salix drug for ulcerative colitis
FDLI SmartBrief | Dec 30, 2008
Study: Aerobic exercise best at curbing appetite
FDLI SmartBrief | Dec 30, 2008
FDLI News
More >
Register today for the 2nd Annual Conference on Nanotechnology Law, Regulation and Policy, Feb. 18 to 19
FDLI SmartBrief | Jan 05, 2009
Preview, purchase your copy of Off-Label Communications: A Guide to Sales and Marketing Compliance
FDLI SmartBrief | Jan 05, 2009
New conference! Waxman-Hatch: Back to the Future
FDLI SmartBrief | Jan 02, 2009
Attention all new law firm associates, regulatory affairs manager or Capitol Hill staffers do you need a good overview of drug law and regulation? Register for Introduction to Drug Law and Regulation
FDLI SmartBrief | Jan 02, 2009
Dietary Supplements Issues & Trends conference. Earn CLEs!
FDLI SmartBrief | Dec 31, 2008
Latest Health Care Industry Press ReleasesMore >
Zacks Industry Outlook Highlights: Pfizer, Bristol-Myers, Johnson & Johnson, Merck and Eli Lilly
Business Wire | 17 minutes ago
ZymoGenetics to Webcast Presentation at J.P. Morgan Healthcare Conference
Business Wire | 17 minutes ago
WuXi AppTec Selects H-Cube from ThalesNano for Laboratory-based Hydrogenation
PRNewswire | 17 minutes ago
Zacks Analyst Blog Highlights: Colgate-Palmolive, Johnson & Johnson, AAON, Granite Corp. and URS
Business Wire | 17 minutes ago
Sign up for FDLI SmartBrief
Latest Blog Postsview more
Business of Biotech Conference At Moffitt Cancer Center
BioTech Weblog, The
Volcanoes cool the tropics
Science Blog
Doubts make consumers more willing to reevaluate brands
Science Blog
Stars forming just beyond black hole
Science Blog
Job Listingsview more
- Associate General Counsel - Regulatory
Cardinal Health - Corporate Counsel
Genentech
Companies in the news
- Alexion Pharmaceuticals
- Amgen Inc.
- Arrow International Inc.
- Biovail Corp
- Caraco Pharmaceutical
- CareFirst
- Genentech Inc
- Gilead Sciences Inc
- Health Care
- Labopharm Inc
- Pfizer Inc.
- Purdue Pharma L.P.
- Ranbaxy Laboratories Ltd.
- Sandoz Inc
- Sankyo Co LTD
Recent Poll view more polls